MX9801129A - Agentes farmaceuticos. - Google Patents

Agentes farmaceuticos.

Info

Publication number
MX9801129A
MX9801129A MX9801129A MX9801129A MX9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A
Authority
MX
Mexico
Prior art keywords
hydrogen
pharmaceutical agents
formula
inhibitin
cycloalky
Prior art date
Application number
MX9801129A
Other languages
English (en)
Inventor
Mitchell Irvin Steinberg
Fatima Emitel Yakubu-Madus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9801129A publication Critical patent/MX9801129A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion proporciona un procedimiento para inhibir el deterioro del metabolismo de la glucosa en un mamífero administrado una aminopirimidina sustituida que tiene la formula (Ver Formula) en laque R1, R2 y R3 son, independientemente, hidrogeno, halogeno, alcoxi C1-C4, (alquilo C1-C4)tio, alquilo C1-C4 o cicloalquilo C1-C3; R4 es hidrogeno, formilo, acetilo, propionilo o butirilo, a condicion de que R1,R4 no sean todos hidrogeno al mismo tiempo; o una sal o solvato farmacéuticamente aceptable del mismo.
MX9801129A 1997-02-11 1998-02-10 Agentes farmaceuticos. MX9801129A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79866197A 1997-02-11 1997-02-11

Publications (1)

Publication Number Publication Date
MX9801129A true MX9801129A (es) 1998-11-29

Family

ID=25173964

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801129A MX9801129A (es) 1997-02-11 1998-02-10 Agentes farmaceuticos.

Country Status (12)

Country Link
EP (1) EP0857483A1 (es)
JP (1) JPH10218773A (es)
KR (1) KR19980071226A (es)
AU (1) AU5387898A (es)
CA (1) CA2229123A1 (es)
CZ (1) CZ39398A3 (es)
HU (1) HUP9800291A2 (es)
IL (1) IL123232A0 (es)
MX (1) MX9801129A (es)
NO (1) NO980546L (es)
SG (1) SG76535A1 (es)
ZA (1) ZA981029B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
ITTV20010002U1 (it) 2001-01-12 2002-07-12 Vetraria Biancadese Sas Soc Tavolo avente almeno una prolunga estraibile mediante semplice rotazione
PL377847A1 (pl) 2003-01-14 2006-02-20 Arena Pharmaceuticals Inc. 1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia
EP1606282B1 (en) * 2003-02-24 2008-11-12 Arena Pharmaceuticals, Inc. Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
BRPI0415198A (pt) * 2003-10-10 2006-12-05 Solvay Pharm Gmbh composição farmacêutica compreendendo um agonista seletivo do receptor da imidazolina i1 e um bloqueador do receptor da angiotensina ii
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
EP1981498A2 (en) * 2006-01-27 2008-10-22 F. Hoffmann-la Roche AG Use of 2-imidazoles for the treatment of cns disorders
ES2381589T3 (es) 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
WO2008052907A1 (en) 2006-11-02 2008-05-08 F. Hoffmann-La Roche Ag Substituted 2-imidazoles as modulators of the trace amine associated receptors
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
AU2007332641A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (TAAR)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
RU2473545C2 (ru) 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
RU2460725C2 (ru) 2007-02-15 2012-09-10 Ф. Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1
MX2009013742A (es) 2007-07-02 2010-01-26 Hoffmann La Roche 2-imidazolinas.
AU2008270444A1 (en) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
RU2010104632A (ru) 2007-07-27 2011-09-20 Ф.Хоффманн-Ля Рош Аг (Ch) 2-азетидинметанамины и 2-пирролидинметанамины в качестве лигандов taar
JP5341084B2 (ja) 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
SI3310760T1 (sl) 2015-06-22 2023-02-28 Arena Pharmaceuticals, Inc. Kristalinična L-argininska sol (R)-2-(7-(4-ciklopentil-3-(trifluorometil)benziloksi)-1,2,3,4- tetrahidrociklo-penta(b)indol-3-il)ocetne kisline za uporabo pri motnjah, povezanih z receptorjem S1P1
RU2731095C2 (ru) 2016-03-17 2020-08-28 Ф. Хоффманн-Ля Рош Аг Производное 5-этил-4-метил-пиразол-3-карбоксамида, обладающее активностью агониста taar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel

Also Published As

Publication number Publication date
JPH10218773A (ja) 1998-08-18
KR19980071226A (ko) 1998-10-26
AU5387898A (en) 1998-08-13
IL123232A0 (en) 1999-11-30
HU9800291D0 (en) 1998-04-28
EP0857483A1 (en) 1998-08-12
CA2229123A1 (en) 1998-08-11
NO980546L (no) 1998-08-12
HUP9800291A2 (hu) 2001-02-28
NO980546D0 (no) 1998-02-09
CZ39398A3 (cs) 1998-08-12
SG76535A1 (en) 2000-11-21
ZA981029B (en) 1999-08-10

Similar Documents

Publication Publication Date Title
MX9801129A (es) Agentes farmaceuticos.
KR960701055A (ko) 인터로이킨-1 및 종양 괴사 인자 억제 활성을 지닌 피라졸로트리아진 (pyrazol itriazines with interleukin-1 and tumour necrosis factor in-hibitory actvity)
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
AU4950993A (en) Combination of germicidal agents
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
IL142649A0 (en) Azole derivatives
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
BG103735A (en) Method for the preparation of substituted thiazolidindions
MY117086A (en) 3''-aziridino-anthracycline derivatives.
TW350838B (en) Quinoline derivatives
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
ATE282608T1 (de) Chinoxalindionen
TW259787B (es)
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
TW329388B (en) Intraocular irrigating solution
CA2232267A1 (en) Novel imidazole lipoxygenase inhibitors
MY131931A (en) Methods of inhibiting primary endometrial hyperplasia
ZA9810361B (en) Heterocyclic compounds having MMP and TNF inhibitory activity.